Lidak Pharmaceuticals – Trademark Portfolio

Entity Type: 03

Lidak Pharmaceuticals holds 11 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 7 filings in this category. The portfolio also extends into Class 1 (Chemicals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include ABREVA. The owner is based in La Jolla, CA.

11077 North Torrey Pines Road

La Jolla, CA 92037

11 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Lidak Pharmaceuticals's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (7 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

1
Chemicals (3 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Lidak Pharmaceuticals have?

Lidak Pharmaceuticals has 11 U.S. trademarks filed with the USPTO. Of these, 1 registered, 9 abandoned, 1 cancelled.

What trademark classes does Lidak Pharmaceuticals file in?

Lidak Pharmaceuticals files trademarks across 3 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 1 (Chemicals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are Lidak Pharmaceuticals's most well-known trademarks?

Lidak Pharmaceuticals's registered trademark portfolio includes well-known marks such as ABREVA. These are among 1 currently registered trademark in the portfolio.

What is Lidak Pharmaceuticals's trademark registration success rate?

Lidak Pharmaceuticals has a 9% trademark registration rate, with 1 out of 11 resolved applications resulting in successful registration. Currently, 0 applications are pending review.